Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas B Dschietzig

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|May 31, 2016
The actions of relaxin on the human cardiovascular systemMohsin Sarwar, Xiao-Jun Du, Thomas B Dschietzig, et al.
Pharmacological Reviews|March 13, 2015
International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptidesMichelle L Halls, Ross A D Bathgate, Steve W Sutton, et al.
Clinical Laboratory|February 7, 2017
Plasma Zonulin and its Association with Kidney Function, Severity of Heart Failure, and Metabolic InflammationThomas B Dschietzig, Felix Boschann, Jana Ruppert, et al.
Clinical Laboratory|December 12, 2017
Homoarginine Associates with Zonulin and Tryptophan - Findings in a High-Risk Cohort of Patients Carrying an AICDElli Mann, Robert Kluesener, Felix Boschann, et al.
Scientific Reports|December 19, 2025
Low-grade, systemic inflammation and the risk of perioperative neurocognitive disorders in an observational study of older adultsInsa Feinkohl, Daniel Hadzidiakos, Thomas B Dschietzig, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Therapeutic potential of Relaxin-2 in Heart Failure with preserved Ejection Fraction (HFpEF)Joshua B Palma, Bethann Gabris-Weber, Brenda McMahon, et al.
BMJ Nutrition, Prevention & Health|January 30, 2025
Haptoglobin polymorphism, vitamin E and mortality: the Ludwigshafen Risk and Cardiovascular Health StudyGraciela E Delgado, Marcus E Kleber, Angela P Moissl, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|May 31, 2016
The actions of relaxin on the human cardiovascular systemMohsin Sarwar, Xiao-Jun Du, Thomas B Dschietzig, et al.
Pharmacological Reviews|March 13, 2015
International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptidesMichelle L Halls, Ross A D Bathgate, Steve W Sutton, et al.
Clinical Laboratory|February 7, 2017
Plasma Zonulin and its Association with Kidney Function, Severity of Heart Failure, and Metabolic InflammationThomas B Dschietzig, Felix Boschann, Jana Ruppert, et al.
Clinical Laboratory|December 12, 2017
Homoarginine Associates with Zonulin and Tryptophan - Findings in a High-Risk Cohort of Patients Carrying an AICDElli Mann, Robert Kluesener, Felix Boschann, et al.
Scientific Reports|December 19, 2025
Low-grade, systemic inflammation and the risk of perioperative neurocognitive disorders in an observational study of older adultsInsa Feinkohl, Daniel Hadzidiakos, Thomas B Dschietzig, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Therapeutic potential of Relaxin-2 in Heart Failure with preserved Ejection Fraction (HFpEF)Joshua B Palma, Bethann Gabris-Weber, Brenda McMahon, et al.
BMJ Nutrition, Prevention & Health|January 30, 2025
Haptoglobin polymorphism, vitamin E and mortality: the Ludwigshafen Risk and Cardiovascular Health StudyGraciela E Delgado, Marcus E Kleber, Angela P Moissl, et al.
Pageof 1